ArticleToxins2023

A Novel EGFR Targeted Immunotoxin Based on Cetuximab and Type 1 RIP Quinoin Overcomes the Cetuximab Resistance in Colorectal Cancer Cells.

Nicola Landi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.